Citations

Clear

613 citation(s) found for "Dingli, David".

Artificial Intelligence-Enhanced Models to Predict Light Chain Amyloidosis from Patients with Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma
Dasari, Surendra , Grogan, Martha , Lacy, Martha Q. , Kourelis, Taxiarchis , Attia, Itzhak Z., Lopez‐Jimenez, Francisco, Murphree, Dennis H. , Friedman, Paul A. , Kumar, Shaji , Muchtar, Eli , Gertz, Morie A. , Buadi, Francis K. , Dingli, David , Attia, Itzhak Z., López-Jiménez, Francisco , Dispenzieri, Angela

Mayo Clinic

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7230-7232

10.1182/blood-2022-168119 Get It

Persistance or Reappearance of Serum Monoclonal Protein Detected By Mass Spectrometry Is a Major Prognostic Factor in Patients with Newly Diagnosed Multiple Myeloma
Murray, David , Kapoor, Prashant , Fonder, Amie , Hayman, Suzanne R. , Hobbs, Miriam, Hwa, Yi L., Kourelis, Taxiarchis , Lacy, Martha Q. , Lin, Yi , Warsame, Rahma , Kyle, Robert A. , Kumar, Shaji , Claveau, Jean‐Sébastien , Dispenzieri, Angela , Binder, Moritz , Buadi, Francis K. , Dingli, David , Gertz, Morie A. , Gonsalves, Wilson I. , Leung, Nelson , Rajkumar, S. Vincent

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2347-2348

10.1182/blood-2022-167430 Get It

Impact of Pegcetacoplan on Paroxysmal Nocturnal Hemoglobinuria Symptoms in Patients Previously Treated with C5-Inhibitors
Desai, Dharmik, Hadker, Nandini, Perler, Jed, O'Hara, Matthew, Hill, Laura, Dingli, David

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 11443-11444

10.1182/blood-2022-163778 Get It

Health-Related Quality of Life Reported Among Patients with Paroxysmal Nocturnal Hemoglobinuria: Impact of Treatment with Pegcetacoplan and C5-Inhibitors
Desai, Dharmik, Hadker, Nandini, Francis, Amanda, Torres, Amanda Cassidy, Perler, Jed, Francis, Amanda, Hill, Laura, Dingli, David

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 11445-11446

10.1182/blood-2022-163821 Get It

Fixed Duration Daratumumab, Ixazomib, Lenalidomide, and Dexamethasone Quadruplet for Newly Diagnosed Multiple Myeloma - MRD Negativity and Survival Outcomes
Kumar, Shaji , LaPlant, Betsy, Asmus, Erik, Thompson, Melanie , Warsame, Rahma , Kourelis, Taxiarchis , Hwa, Yi L. , Fonder, Amie , Hobbs, Miriam, Lacy, Martha Q. , Hayman, Suzanne R. , Kapoor, Prashant , Buadi, Francis K. , Gonsalves, Wilson I. , Muchtar, Eli , Dingli, David , Thompson, Melanie Ann, Go, Ronald S. , Dispenzieri, Angela , Leung, Nelson , Binder, Moritz , Rajkumar, S. Vincent , Gertz, Morie A.

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10142-10143

10.1182/blood-2022-169046 Get It